PT-141 bremelanotide
Selected indexed studies
- PT-141 Palatin. (Curr Opin Investig Drugs, 2004) [PMID:15134289]
- Medical Treatment of Female Sexual Dysfunction. (Urol Clin North Am, 2022) [PMID:35428435]
- Bremelanotide. (, 2006) [PMID:31369224]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- PT-141 Palatin. (2004) pubmed
- Medical Treatment of Female Sexual Dysfunction. (2022) pubmed
- Bremelanotide. (2006) pubmed
- Bremelanotide. (2012) pubmed
- Bremelanotide: First Approval. (2019) pubmed
- Hypoactive Sexual Desire Disorder in Women: Physiology, Assessment, Diagnosis, and Treatment. (2021) pubmed
- An effect on the subjective sexual response in premenopausal women with sexual arousal disorder by bremelanotide (PT-141), a melanocortin receptor agonist. (2006) pubmed
- Targeting the central melanocortin system for the treatment of metabolic disorders. (2023) pubmed
- Bremelanotide: New Drug Approved for Treating Hypoactive Sexual Desire Disorder. (2020) pubmed
- Small Effects, Questionable Outcomes: Bremelanotide for Hypoactive Sexual Desire Disorder. (2024) pubmed